These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 30290801

  • 1. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
    Tashkin DP, Miravitlles M, Celli BR, Metzdorf N, Mueller A, Halpin DMG, Anzueto A.
    Respir Res; 2018 Oct 05; 19(1):196. PubMed ID: 30290801
    [Abstract] [Full Text] [Related]

  • 2. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
    Morjaria JB, Rigby A, Morice AH.
    Lung; 2017 Jun 05; 195(3):281-288. PubMed ID: 28255905
    [Abstract] [Full Text] [Related]

  • 3. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
    Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM.
    Lancet Respir Med; 2016 May 05; 4(5):390-8. PubMed ID: 27066739
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.
    Choi JH, Jeong KB, Park YH, Yu I, Lee SJ, Lee MK, Kim SH, Lee WY, Yong SJ, Lee JH.
    Int J Chron Obstruct Pulmon Dis; 2021 May 05; 16():3229-3237. PubMed ID: 34858023
    [Abstract] [Full Text] [Related]

  • 5. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.
    Kew KM, Seniukovich A.
    Cochrane Database Syst Rev; 2014 Mar 10; 2014(3):CD010115. PubMed ID: 24615270
    [Abstract] [Full Text] [Related]

  • 6. Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study.
    Lee JH, Park YH, Kang DR, Lee SJ, Lee MK, Kim SH, Yong SJ, Lee WY.
    Int J Chron Obstruct Pulmon Dis; 2020 Mar 10; 15():3397-3406. PubMed ID: 33402820
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar 10; 11():2341-2348. PubMed ID: 27703344
    [Abstract] [Full Text] [Related]

  • 8. Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD.
    Chang TY, Chien JY, Wu CH, Dong YH, Lin FJ.
    Chest; 2020 May 10; 157(5):1117-1129. PubMed ID: 31887282
    [Abstract] [Full Text] [Related]

  • 9. Reported pneumonia in patients with COPD: findings from the INSPIRE study.
    Calverley PMA, Stockley RA, Seemungal TAR, Hagan G, Willits LR, Riley JH, Wedzicha JA, Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) Investigators.
    Chest; 2011 Mar 10; 139(3):505-512. PubMed ID: 20576732
    [Abstract] [Full Text] [Related]

  • 10. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
    Wang CY, Lai CC, Yang WC, Lin CC, Chen L, Wang HC, Yu CJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar 10; 11():2775-2783. PubMed ID: 27877031
    [Abstract] [Full Text] [Related]

  • 11. Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
    Lodise TP, Li J, Gandhi HN, O'Brien G, Sethi S.
    Int J Chron Obstruct Pulmon Dis; 2020 Mar 10; 15():2889-2900. PubMed ID: 33204085
    [Abstract] [Full Text] [Related]

  • 12. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
    Pavord ID, Lettis S, Anzueto A, Barnes N.
    Lancet Respir Med; 2016 Sep 10; 4(9):731-741. PubMed ID: 27460163
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database.
    Quint JK, Montonen J, Esposito DB, He X, Koerner L, Wallace L, de la Hoz A, Miravitlles M.
    Adv Ther; 2021 May 10; 38(5):2249-2270. PubMed ID: 33721209
    [Abstract] [Full Text] [Related]

  • 14. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.
    Nannini LJ, Poole P, Milan SJ, Kesterton A.
    Cochrane Database Syst Rev; 2013 Aug 30; 2013(8):CD006826. PubMed ID: 23990350
    [Abstract] [Full Text] [Related]

  • 15. Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
    Sonnappa S, Martin R, Israel E, Postma D, van Aalderen W, Burden A, Usmani OS, Price DB, Respiratory Effectiveness Group, Small Airways Study Group.
    PLoS One; 2017 Aug 30; 12(6):e0178112. PubMed ID: 28617814
    [Abstract] [Full Text] [Related]

  • 16. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC.
    Respir Med; 2017 Sep 30; 130():75-84. PubMed ID: 29206637
    [Abstract] [Full Text] [Related]

  • 17. The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
    Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L.
    Int J Chron Obstruct Pulmon Dis; 2016 Sep 30; 11():193-205. PubMed ID: 26893551
    [Abstract] [Full Text] [Related]

  • 18. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S, Karner C, Cates CJ, Evans DJ.
    Cochrane Database Syst Rev; 2011 Dec 07; 2011(12):CD007033. PubMed ID: 22161409
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S, Evans DJ, Karner C, Cates CJ.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007033. PubMed ID: 21975759
    [Abstract] [Full Text] [Related]

  • 20. Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD.
    Soltani A, Walters EH, Reid DW, Shukla SD, Nowrin K, Ward C, Muller HK, Sohal SS.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct 05; 11():2359-2367. PubMed ID: 27703346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.